Medicare Enrolled

Dr. Saad Munib Ahmed Khan, MD

Hematology · Stanford, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
300 PASTEUR DR, Stanford, CA 94305
6507234000
In practice since 2007 (19 years)
NPI: 1083767024 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khan

Dr. Saad Munib Ahmed Khan is a hematology specialist in Stanford, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 843 Medicare services across 345 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khan received a total of $294,019 from 36 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 30% volume in CA $294,019 industry payments

Medicare Practice Summary

Medicare Utilization ↗
843
Medicare services
Top 30% in CA for hematology
345
Unique beneficiaries
$122
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
491 $131 $233
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
160 $81 $210
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
98 $110 $368
New patient office visit, complex (60-74 min) 66 $168 $288
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
16 $160 $757
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
12 $76 $306
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$294,019
Total received (2018-2024)
Avg $42,003/year across 7 years
Top 6% in CA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$240,829 (81.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51,295 (17.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,895 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,267
2023
$42,356
2022
$74,732
2021
$63,291
2020
$54,583
2019
$19,816
2018
$31,975

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genmab U.S., Inc.
$5,689
Coherus Biosciences Inc.
$1,350
ABBVIE INC.
$63
Regeneron Healthcare Solutions, Inc.
$45
Astellas Pharma US Inc
$42
Daiichi Sankyo Inc.
$29
Janssen Biotech, Inc.
$26
Incyte Corporation
$23
Top 3 companies account for 97.7% of 2024 payments
All-time payments by company (2018-2024) ›
Foundation Medicine, Inc.
$238,208
Takeda Pharmaceuticals U.S.A., Inc.
$14,834
Eisai Inc.
$8,315
Bayer HealthCare Pharmaceuticals Inc.
$6,214
Coherus Biosciences Inc.
$5,893
Genmab U.S., Inc.
$5,689
Genentech, Inc.
$4,708
EISAI INC.
$3,863
Genentech USA, Inc.
$3,072
Merck KGaA
$1,725
Amgen Inc.
$150
Incyte Corporation
$150
Novartis Pharmaceuticals Corporation
$128
Astellas Pharma US Inc
$124
E.R. Squibb & Sons, L.L.C.
$118
Merck Sharp & Dohme Corporation
$101
ABBVIE INC.
$88
AstraZeneca Pharmaceuticals LP
$76
Janssen Biotech, Inc.
$64
Lilly USA, LLC
$57
Eli Lilly and Company
$52
BIOTRONIK INC.
$46
Regeneron Healthcare Solutions, Inc.
$45
Mylan Institutional Inc.
$44
Pharmacyclics LLC, An AbbVie Company
$35
Alexion Pharmaceuticals, Inc.
$32
Daiichi Sankyo Inc.
$29
GENZYME CORPORATION
$24
AbbVie, Inc.
$21
Taiho Oncology, Inc.
$20
Clovis Oncology, Inc.
$19
Seattle Genetics, Inc.
$19
Biogen, Inc.
$15
Celgene Corporation
$15
Tactile Systems Technology Inc
$13
PFIZER INC.
$13
Top 3 companies account for 88.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Avastin · CALQUENCE · CHANTIX · ERLEADA · Enhertu · FASLODEX · FLEXITOUCH · FOUNDATIONONE CDX · FOUNDATIONONE LIQUID · Fulphila · GAUCHER-DISEASE · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LOQTORZI · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · NINLARO · Neulasta · Non-Covered · Nplate · OPDIVO · PEMAZYRE · PIQRAY · Padcev · Rubraca · SOLIRIS · TAGRISSO · TECENTRIQ · TYSABRI · Tivdak · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · Venclexta · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for hematology in CA.

Looking for a hematology specialist in Stanford?
Compare hematologists in the Stanford area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
25
Per 100K population
1.3
County median income
$159,674
Nearest hospital
STANFORD HEALTH CARE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with consulting-driven industry engagement in the top 6% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khan experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Khan performed 491 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $294,019 from 36 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other hematologists in Stanford?
Dr. Khan's average Medicare payment per service is $122. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →